Aviva launches Global Equity Endurance fund for Parkinson

Aviva Investors has launched a Global Equity Endurance Sicav for Giles Parkinson.

Aviva launches Global Equity Endurance fund for Parkinson

|

A high-conviction, low turnover portfolio of 25 holdings, all global equities, will aim to deliver a consistent return over the long term.

Parkinson, who joined from Artemis last year, will run the fund, with support from Richard Saldanha and Helen Driver in the global equities team.

Parkinson said: “The quality of the businesses we select will be key to the success of the fund. We invest in a small number of superior and resilient companies that have stood the test of time and we believe will continue to do so indefinitely.”

Global head of equities Chris Murphy said the launch was part of the continual “evolution” of its equity offering.

“The new fund reinforces our commitment to becoming a leader in outcome-oriented solutions in response to changing client needs.”

Parkinson added: “Given the long-term and enduring nature of these businesses, we cite the fund’s investment horizon as ‘over five years.’ However, we manage this strategy such that clients can hold the fund indefinitely, which we believe makes it a compelling choice as a core long-term investment. The portfolio is unconstrained, allowing us to invest without restriction; choosing the very best businesses regardless of sector classification or geographic listing.”

The fund is domiciled in Luxembourg; a Sicav with US dollar as its base currency.

Charges will be 1.5% AMC for the retail share class and 0.75% for institutional.

MORE ARTICLES ON